Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
|---|---|
| pe ratio | -5.26 |
| peg ratio | 0.15 |
| price to book ratio | -1.23 |
| price to sales ratio | 1.56 |
| enterprise value multiple | -11.68 |
| price fair value | -1.23 |
profitability ratios | |
|---|---|
| gross profit margin | 81.57% |
| operating profit margin | 5.57% |
| pretax profit margin | -29.37% |
| net profit margin | -29.37% |
| return on assets | -27.62% |
| return on equity | 23.71% |
| return on capital employed | 11.1% |
liquidity ratio | |
|---|---|
| current ratio | 1.85 |
| quick ratio | 1.37 |
| cash ratio | 0.87 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 537.07 |
| operating cycle | 620.86 |
| days of payables outstanding | 233.76 |
| cash conversion cycle | 387.10 |
| receivables turnover | 4.36 |
| payables turnover | 1.56 |
| inventory turnover | 0.68 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.84 |
| debt equity ratio | -0.71 |
| long term debt to capitalization | -2.45 |
| total debt to capitalization | -2.45 |
| interest coverage | 0.28 |
| cash flow to debt ratio | -0.10 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.13 |
| cash per share | 0.74 |
| operating cash flow per share | -0.13 |
| free cash flow operating cash flow ratio | 1.01 |
| cash flow coverage ratios | -0.10 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -81.26 |
Frequently Asked Questions
Esperion Therapeutics, Inc. (ESPR) published its most recent earnings results on 07-11-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Esperion Therapeutics, Inc. (NASDAQ:ESPR)'s trailing twelve months ROE is 23.71%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Esperion Therapeutics, Inc. (ESPR) currently has a ROA of -27.62%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
ESPR reported a profit margin of -29.37% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.85 in the most recent quarter. The quick ratio stood at 1.37, with a Debt/Eq ratio of -0.71.